Source: Eur Respir J 2008; 32: 924-930
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Wu S-G., Gow C-H., Yu C-J., Chang Y-L., Yang C-H., Hsu Y-C., Shih J-Y., Lee Y-C., Yang P-C.. Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma. Eur Respir J 2008; 32: 924-930

Member's Comments

No comment yet.

Related content which might interest you: RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer Source: Eur Respir J 2012; 39: 677-684 Year: 2012 Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis Source: Eur Respir J 2013; 41: 417-424 Year: 2013 EGFR-TKI and lung adenocarcinoma with CNS relapse: interest of molecular follow-up Source: Eur Respir J 2009; 33: 436-440 Year: 2009 Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions Source: Eur Respir J 2003; 21: 611-615 Year: 2003 Vascular endothelial growth factor (VEGF) in malignant and tuberculous pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001 Clinical features associated with epidermal growth factor receptor and K-RAS gene mutations in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 811s Year: 2006 Survival of lung adenocarcinoma patients with malignant pleural effusion Source: Eur Respir J 2013; 41: 1409-1418 Year: 2013 Identification of differentially expressed proteins in human malignant pleural effusions Source: Eur Respir J 2006; 28: 1178-1185 Year: 2006 Characteristics of common and uncommon epidermal growth factor receptros gene mutations in patients with non small cell lung cancer Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Increased expression of angiogenic growth factor stromal cell derived factor-1 (SDF-1/CXCL12) in pleural fluid of patients with lung cancer: preliminary results Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer Source: Eur Respir J 2011; 37: 183-193 Year: 2011 A blood-based test for epidermal growth factor receptor mutations in patients with non-small cell lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008 Detection of epidermal growth factor receptor mutation in plasma as predictor of gefitinib response in non small cell lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008 The prognostic value of serum epidermal growth factor receptor (EGFR) levels in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 674s Year: 2004 Is pleural VEGF a useful parameter? Source: Annual Congress 2007 - Pleural malignancy Year: 2007 Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001 Stage IV adenocarcinoma of the lung with classical epidermal growth factor receptor mutation and a thought-provoking course Source: Virtual Congress 2021 – Lung cancer grand round Year: 2021 Epidermal growth factor receptor mutation status in advanced non-small cell lung cancer: A single institution experience Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung cancer and its correlation with survival Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009